August

August

Fighting Cancer from Within

By Administrator at 11 Aug 2020

Among many advances in oncology over the past decade, the most striking may be the growing field of immunotherapy. The U.S. Food & Drug Administration has approved immunotherapies for some two dozen cancer types – from successful CAR T-cell therapy for acute lymphoblastic leukemia, to PD-1 checkpoint inhibitors for melanoma and non-small cell lung cancer, to therapeutic vaccines for pancreatic cancer. Thousands of clinical trials currently underway hold promise for more progress to come.

0 comments posted

    Categories

    Archive

    2020 2019 2018 2017 2016 2015
    99 cents of every dollar received directly funds cancer clinical trials

    52

    Current Gateway-funded clinical trials

    180+

    Clinical trials funded at leading institutions worldwide

    $16.56

    Funds one patient for one day at a Gateway-funded clinical trial

     
     

    Mission Partners